Cập nhật ấn phẩm về nghiên cứu kháng thuốc sốt rét trên toàn cầu đến tháng 10/2015

1.Kim S, Nhem S, Dourng D and Ménard D. 2015. Malaria rapid diagnostic test as point‐of‐care test: study protocol for evaluating the VIKIA® Malaria Ag Pf/Pan. Malaria journal, 14.

2.Menard D and Ariey F. 2015. Towards real‐time monitoring of artemisinin resistance. The Lancet. Infectious diseases, 15, 367‐368.

3.Canier L, Khim N, Kim S, Eam R, Khean C, Loch K, Ken M, Pannus P, Bosman P, Stassijns J, Nackers F, Alipon S, Char MC, Chea N, Etienne W, De Smet M, Kindermans J and Ménard D. 2015. Malaria PCR detection in Cambodian low‐transmission settings: dried blood spots versus venous blood samples. The American journal of tropical medicine and hygiene, 92, 573‐577.

4.Straimer J, Gnädig NF, Witkowski B, Amaratunga C, Duru V, Ramadani AP, Dacheux M, Khim N, Zhang L, Lam S, Gregory PD, Urnov FD, Mercereau‐Puijalon O, Benoit‐Vical F, Fairhurst RM, Ménard D and Fidock DA. 2015. Drug resistance. K13‐propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates. Science (New York, N.Y.), 347, 428‐431.

5.Roca‐Feltrer A, Khim N, Kim S, Chy S, Canier L, Kerleguer A, Tor P, Chuor CM, Kheng S, Siv S, Kachur PS, Taylor WR, Hwang J and Menard D. 2014. Field trial evaluation of the performances of point‐of‐care tests for screening G6PD deficiency in Cambodia. PloS o­ne, 9.

6.Torrentino‐Madamet M, Fall B, Benoit N, Camara C, Amalvict R, Fall M, Dionne P, Fall KB, Nakoulima A, Diatta B, Diemé Y, Ménard D, Wade B and Pradines B. 2014. Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012‐2013. Malaria journal, 13.

7.Malmquist NA, Sundriyal S, Caron J, Chen P, Witkowski B, Menard D, Suwanarusk R, Renia L, Nosten F, Jiménez‐Díaz MB, Angulo‐Barturen I, Martínez MS, Ferrer S, Sanz LM, Gamo F, Wittlin S, Duffy S, Avery VM, Ruecker A, Delves MJ, Sinden RE, Fuchter MJ and Scherf A. 2014. Histone methyltransferase inhibitors: orally bioavailable, fast acting molecules with activity against different human malaria species. Antimicrobial agents and chemotherapy

8.Popovici J, Kao S, Eal L, Bin S, Kim S and Ménard D. 2014. short report: reduced polymorphism in p. vivax kelch‐propeller domain in cambodian isolates. Antimicrobial agents and chemotherapy.

9.Bosman P, Stassijns J, Nackers F, Canier L, Kim N, Khim S, Alipon SC, Char MC, Chea N, Dysoley L, Van den Bergh R, Etienne W, De Smet M, Ménard D and Kindermans J. 2014. Plasmodium prevalence and artemisinin‐resistant falciparum malaria in Preah Vihear Province, Cambodia: a cross‐sectional population‐based study. Malaria journal,

10.Sluydts V, Heng S, Coosemans M, Van Roey K, Gryseels C, Canier L, Kim S, Khim N, Siv S, Mean V, Uk S, Grietens KP, Tho S, Menard D and Durnez L. 2014. Spatial clustering and risk factors of malaria infections in Ratanakiri Province, Cambodia. Malaria journal,

11.Khim N, Andrianaranjaka V, Popovici J, Kim S, Ratsimbasoa A, Benedet C, Barnadas C, Durand R, Thellier M, Legrand E, Musset L, Menegon M, Severini C, Nour BY, Tichit M, Bouchier C, Mercereau‐Puijalon O and Ménard D. 2014. Effects of Mefloquine Use o­n Plasmodium vivax multidrug resistance. Emerging infectious diseases, 20, 1629‐1636.

12.Menegon M, Durand P, Menard D, Legrand E, Picot S, Nour B, Davidyants V, Santi F and Severini C. 2014. Genetic diversity and population structure of Plasmodium vivax isolates from Sudan, Madagascar, French Guiana and Armenia. Infection, genetics and evolution: Journal of molecular epidemiology and evolutionary genetics in infectious diseases, 27C, 244‐249.

13.Khim N, Witkowski B, Duru V, Ariey F, Mercereau‐Puijalon O and Ménard D. 2014. Towards a better understanding of the molecular mechanisms of P. falciparum resistance to artemisinin. Médecine sciences: M/S, 30, 727‐729.

14.Takala‐Harrison S, Jacob CG, Arze C, Cummings MP, Silva JC, Dondorp AM, Fukuda MM, Hien TT, Mayxay M, Noedl H, Nosten F, Kyaw MP, Nhien NT, Imwong M, Bethell D, Se Y, Lon C, Tyner SD, Saunders DL, Ariey F, Mercereau‐Puijalon O, Menard D, Newton PN, Khanthavong M, Hongvanthong B, Starzengruber P, Fuehrer H, Swoboda P, Khan WA, Phyo AP, Nyunt MM, Nyunt MH, Brown TS, Adams M, Pepin CS, Bailey J, Tan JC, Ferdig MT, Clark TG, Miotto O, MacInnis B, Kwiatkowski DP, White NJ, Ringwald P and Plowe CV. 2014. Independent emergence of Plasmodium falciparum artemisinin resistance mutations in Southeast Asia. The Journal of infectious diseases.

15.Roper C, Alifrangis M, Ariey F, Talisuna A, Menard D, Mercereau‐Puijalon O and Ringwald P. 2014. Molecular surveillance for artemisinin resistance in Africa. The Lancet. Infectious diseases, 14, 668‐670.

16.Venkatesan M, Gadalla NB, Stepniewska K, Dahal P, Nsanzabana C, Moriera C, Price RN, Mårtensson A, Rosenthal PJ, Dorsey G, Sutherland CJ, Guérin P, Davis TM, Ménard D, Adam I, Ademowo G, Arze C, Baliraine FN, Berens‐Riha N, Björkman A, Borrmann S, Checchi F, Dhorda MD, Djimdé AA, El‐Sayed BB, Eshetu T, Eyase F, Falade C, Faucher J, Fröberg G, Grivoyannis A, Hamour S, Houzé S, Johnson J, Kamugisha E, Kariuki S, Kiechel J, Kironde F, LeBras PK, Malmberg M, Mwai L, Ngasala B, Nosten F, Nsobya SL, Oguike AN, Otienoburu SD, Ogutu B, Ouédraogo J, Piola P, Rombo L, Schramm B, Somé AF, Thwing J, Ursing J, Wong RP, Zeynudin A, Zongo I, Plowe CV and Sibley CH. 2014. Polymorphisms in Plasmodium falciparum Chloroquine Resistance Transporter and Multidrug Resistance 1 Genes: Parasite Risk Factors that Affect Treatment Outcomes for P. falciparum Malaria after Artemether‐Lumefantrine and Artesunate‐Amodiaquine. The American journal of tropical medicine and hygiene.

17.Amaratunga C, Witkowski B, Dek D, Try V, Khim N, Miotto O, Ménard D and Fairhurst RM. 2014. Plasmodium falciparum founder populations in Western Cambodia have reduced artemisinin sensitivity in vitro. Antimicrobial agents and chemotherapy.

18.Amaratunga C, Witkowski B, Khim N, Menard D and Fairhurst RM. 2014. Artemisinin resistance in Plasmodium falciparum. The Lancet infectious diseases, 14, 449‐450.

19.Yalcindag E, Rougeron V, Elguero E, Arnathau C, Durand P, Brisse S, Diancourt L, Aubouy A, Becquart P, D’Alessandro U, Fontenille D, Gamboa D, Maestre A, Ménard D, Musset L, Noya O, Veron V, Wide A, Carme B, Legrand E, Chevillon C, Ayala FJ, Renaud F and Prugnolle F. 2014. Patterns of selection o­n Plasmodium falciparum erythrocyte‐binding antigens after the colonization of the New World. Molecular ecology, 23, 1979‐1993.

20.Bordbar B, Ndam NT, Renard E, Jafari‐Guemouri S, Tavul L, Jennison C, Gnidehou S, Tahar R, Gamboa D, Bendezu J, Menard D, Barry AE, Deloron P and Sabbagh A. 2014. Genetic diversity of VAR2CSA ID1‐DBL2Xb in worldwide Plasmodium falciparum populations: Impact o­n vaccine design for placental malaria. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 25, 81‐92.

21.Mueller TC, Siv S, Khim N, Kim S, Fleischmann E, Ariey F, Buchy P, Guillard B, González IJ, Christophel E, Abdur R, von Sonnenburg F, Bell D and Menard D. 2014. Acute undifferentiated febrile illness in rural Cambodia: a 3‐year prospective observational study. PloS o­ne.

22.Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois A, Khim N, Kim S, Duru V, Bouchier C, Ma L, Lim P, Leang R, Duong S, Sreng S, Suon S, Chuor CM, Bout DM, Ménard S, Rogers WO, Genton B, Fandeur T, Miotto O, Ringwald P, Le Bras J, Berry A, Barale J, Fairhurst RM, Benoit‐Vical F, Mercereau‐Puijalon O and Ménard D. 2014. A molecular marker of artemisinin‐resistant Plasmodium falciparum malaria. Nature, 505, 50‐55.

23.Hester J, Chan ER, Menard D, Mercereau‐Puijalon O, Barnwell J, Zimmerman PA and Serre D. 2013. De novo assembly of a field isolate genome reveals novel Plasmodium vivax erythrocyte invasion genes. PLoS neglected tropical diseases.

24.Canier L, Khim N, Kim S, Sluydts V, Heng S, Dourng D, Eam R, Chy S, Khean C, Loch K, Ken M, Lim H, Siv S, Tho S, Masse‐Navette P, Gryseels C, Uk S, Van Roey K, Grietens KP, Sokny M, Thavrin B, Chuor CM, Deubel V, Durnez L, Coosemans M and Ménard D. 2013. An innovative tool for moving malaria PCR detection of parasite reservoir into the field. Malaria journal, 12.

25.Gryseels C, Uk S, Erhart A, Gerrets R, Sluydts V, Durnez L, Ribera JM, Muela SH, Menard D, Heng S, Sochantha T, D’Alessandro U, Coosemans M and Grietens KP. 2013. Injections, cocktails and diviners: therapeutic flexibility in the context of malaria elimination and drug resistance in Northeast Cambodia. PloS o­ne, 8.

26.Menard D, Chan ER, Benedet C, Ratsimbasoa A, Kim S, Chim P, Do C, Witkowski B, Durand R, Thellier M, Severini C, Legrand E, Musset L, Nour BY, Mercereau‐Puijalon O, Serre D and Zimmerman PA. 2013. Whole genome sequencing of field isolates reveals a common duplication of the Duffy binding protein gene in Malagasy Plasmodium vivax strains. PLoS neglected tropical diseases, 7.

27.Domingo GJ, Satyagraha AW, Anvikar A, Baird K, Bancone G, Bansil P, Carter N, Cheng Q, Culpepper J, Eziefula C, Fukuda M, Green J, Hwang J, Lacerda M, McGray S, Menard D, Nosten F, Nuchprayoon I, Oo NN, Bualombai P, Pumpradit W, Qian K, Recht J, Roca A, Satimai W, Sovannaroth S, Vestergaard LS and Von Seidlein L. 2013. G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests. Malaria journal, 12.

28.Leang R, Ros S, Duong S, Navaratnam V, Lim P, Ariey F, Kiechel J, Ménard D and Taylor WR. 2013. Therapeutic efficacy of fixed dose artesunate‐mefloquine for the treatment of acute, uncomplicated Plasmodium falciparum malaria in Kampong Speu, Cambodia. Malaria journal, 12.

29.Witkowski B, Amaratunga C, Khim N, Sreng S, Chim P, Kim S, Lim P, Mao S, Sopha C, Sam B, Anderson JM, Duong S, Chuor CM, Taylor WR, Suon S, Mercereau‐Puijalon O, Fairhurst RM and Menard D. 2013. Novel phenotypic assays for the detection of artemisinin‐resistant Plasmodium falciparum malaria in Cambodia: in‐vitro and ex‐vivo drug‐response studies. The Lancet infectious diseases, 13, 1043‐1049.

30.Ménard D, Ariey F and Mercereau‐Puijalon O. 2013. Plasmodium falciparum susceptibility to antimalarial drugs: global data issued from the Pasteur Institutes international network. Médecine sciences : M/S, 29, 647‐655.

31.Taylor JE, Pacheco MA, Bacon DJ, Beg MA, Machado RL, Fairhurst RM, Herrera S, Kim J, Menard D, Póvoa MM, Villegas L, Mulyanto , Snounou G, Cui L, Zeyrek FY and Escalante AA. 2013. The evolutionary history of Plasmodium vivax as inferred from mitochondrial genomes: Parasite genetic diversity in the Americas. Molecular biology and evolution, 30, 2050‐2064.

32.Khim N, Benedet C, Kim S, Kheng S, Siv S, Leang R, Lek S, Muth S, Chea N, Chuor CM, Duong S, Kerleguer A, Tor P, Chim P, Canier L, Witkowski B, Taylor WR and Ménard D. 2013. G6PD deficiency in Plasmodium falciparum and Plasmodium vivax malaria‐infected Cambodian patients. Malaria journal.

33.Bouillon A, Giganti D, Benedet C, Gorgette O, Pêtres S, Crublet E, Girard‐Blanc C, Witkowski B, Ménard D, Nilges M, Mercereau‐Puijalon O, Stoven V and Barale J. 2013. In Silico screening o­n the three‐dimensional model of the Plasmodium vivax SUB1 protease leads to the validation of a novel anti‐parasite compound. The Journal of biological chemistry, 288, 18561‐18573.

34.Woodrow CJ, Dahlström S, Cooksey R, Flegg JA, Le Nagard H, Mentré F, Murillo C, Ménard D, Nosten F, Sriprawat K, Musset L, Quashie NB, Lim P, Fairhurst RM, Nsobya SL, Sinou V, Noedl H, Pradines B, Johnson JD, Guerin PJ, Sibley CH and Le Bras J. 2013. High‐Throughput Analysis of Antimalarial Susceptibility Data by the WorldWide Antimalarial Resistance Network (WWARN) In Vitro Analysis and Reporting Tool. Antimicrobial agents and chemotherapy, 57, 3121‐3130

35.von Seidlein L, Auburn S, Espino F, Shanks D, Cheng Q, McCarthy J, Baird K, Moyes C, Howes R, Ménard D, Bancone G, Winasti‐Satyahraha A, Vestergaard LS, Green J, Domingo G, Yeung S and Price R. 2013. Review of key knowledge gaps in glucose‐6‐phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8‐aminoquinoline treatment regimens: A workshop report. Malaria journal,

36.Witkowski B, Khim N, Chim P, Kim S, Ke S, Kloeung N, Chy S, Duong S, Leang R, Ringwald P, Dondorp AM, Tripura R, Benoit‐Vical F, Berry A, Gorgette O, Ariey F, Barale J, Mercereau‐Puijalon O and Menard D. 2013. Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in western Cambodia. Antimicrob Agents Chemother, 57, 914‐923.

37.Leang R, Barrette A, Bouth DM, Menard D, Abdur R, Duong S and Ringwald P. 2013. Efficacy of dihydroartemisinin‐piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008‐2010. Antimicrob Agents Chemother, 57, 818‐826.

38.Andriantsoanirina V, Khim N, Ratsimbasoa A, Witkowski B, Benedet C, Canier L, Bouchier C, Tichit M, Durand R and Ménard D. 2013. Plasmodium falciparum Na+/H+ exchanger (pfnhe‐1) genetic polymorphism in Indian Ocean malaria‐endemic areas. Am J Trop Med Hyg, 88, 37‐42.

39.Das D, Tripura R, Phyo AP, Lwin KM, Tarning J, Lee SJ, Hanpithakpong W, Stepniewska K, Menard D, Ringwald P, Silamut K, Imwong M, Chotivanich K, Yi P, Day NP, Lindegardh N, Socheat D, Nguon C, White NJ, Nosten F and Dondorp AM. 2013. Effect of high‐dose or split‐dose artesunate o­n parasite clearance in artemisinin‐resistant falciparum malaria. Clin Infect Dis, 56, e48‐e58.

40.Chan ER, Menard D, David PH, Ratsimbasoa A, Kim S, Chim P, Do C, Witkowski B, Mercereau‐Puijalon O, Zimmerman PA and Serre D. 2012. Whole genome sequencing of field isolates provides robust characterization of genetic diversity in Plasmodium vivax. PLoS Negl Trop Dis, 6.

41.Hoyer S, Nguon S, Kim S, Habib N, Khim N, Sum S, Christophel E, Bjorge S, Thomson A, Kheng S, Chea N, Yok S, Top S, Ros S, Sophal U, Thompson MM, Mellor S, Ariey F, Witkowski B, Yeang C, Yeung S, Duong S, Newman RD and Menard D. 2012. Focused Screening and Treatment (FSAT): A PCR‐Based Strategy to Detect Malaria Parasite Carriers and Contain Drug Resistant P. falciparum, Pailin, Cambodia. PLoS o­ne, 7.

42.Acestor N, Cooksey R, Newton PN, Ménard D, Guerin PJ, Nakagawa J, Christophel E, González IJ and Bell D. 2012. Mapping the aetiology of non‐malarial febrile illness in Southeast Asia through a systematic review‐terra incognita impairing treatment policies. PLoS o­ne, 7.

43.Chou M, Kim S, Khim N, Chy S, Sum S, Dourng D, Canier L, Nguon C and Ménard D. 2012. Performance of “VIKIA Malaria Ag Pf/Pan” (IMACCESS®), a new malaria rapid diagnostic test for detection of symptomatic malaria infections. Malar J, 11.

44.Ratsimbasoa A, Ravony H, Vonimpaisomihanta J, Raherinjafy R, Jahevitra M, Rapelanoro R, Rakotomanga JD, Malvy D, Millet P and Ménard D. 2012. Management of uncomplicated malaria in febrile under five‐year‐old children by community health workers in Madagascar: reliability of malaria rapid diagnostic tests. Malar J, 11.

45.Ratsimbasoa A, Ravony H, Vonimpaisomihanta J, Raherinjafy R, Jahevitra M, Rapelanoro R, Rakotomanga JD, Malvy D, Millet P and Ménard D. 2012. Compliance, Safety, and Effectiveness of fixed‐dose artesunate‐amodiaquine for presumptive Treatment of Non‐Severe Malaria in the context of home management of malaria in Madagascar. Am J Trop Med Hyg, 86, 203‐210.

46.Lin JT, Juliano JJ, Kharabora O, Sem R, Lin F, Muth S, Ménard D, Wongsrichanalai C, Rogers WO and Meshnick SR. 2012. Individual Plasmodium vivax msp1 variants within polyclonal P. vivax infections display different propensities for relapse. J Clin Microbiol, 50, 1449‐1451.

47.Yalcindag E, Elguero E, Arnathau C, Durand P, Akiana J, Anderson TJ, Aubouy A, Balloux F, Besnard P, Bogreau H, Carnevale P, D’Alessandro U, Fontenille D, Gamboa D, Jombart T, Le Mire J, Leroy E, Maestre A, Mayxay M, Ménard D, Musset L, Newton PN, Nkoghé D, Noya O, Ollomo B, Rogier C, Veron V, Wide A, Zakeri S, Carme B, Legrand E, Chevillon C, Ayala FJ, Renaud F and Prugnolle F. 2012. Multiple independent introductions of Plasmodium falciparum in South America. Proc Natl Acad Sci USA, 109, 511‐516.

48.Khim N, Kim S, Bouchier C, Tichit M, Ariey F, Fandeur T, Chim P, Ke S, Sum S, Man S, Ratsimbasoa A, Durand R and Ménard D. 2012. Reduced impact of pyrimethamine drug pressure o­n Plasmodium malariae dihydrofolate reductase gene. Antimicrob Agents Chemother, 56, 863‐868.

49.Mercereau‐Puijalon O and Ménard D. 2011. Plasmodium vivax et Groupe sanguin Duffy ‐ Un dogme en évolution Bulletin de l’Association des Anciens Elèves de l’Institut Pasteur, 208, 79.

50.Howes RE, Patil AP, Piel FB, Nyangiri OA, Kabaria CW, Gething PW, Zimmerman PA, Barnadas C, Beall CM, Gebremedhin A, Ménard D, Williams TN, Weatherall DJ and Hay SI. 2011. The global distribution of the Duffy blood group. Nat Commun, 2.

51.Andriantsoanirina V, Ménard D, Tuséo L, Ratsimbasoa A and Durand R. 2011. [Resistance of Plasmodium falciparum to antimalarial drugs: impact o­n malaria pre‐elimination in Madagascar]. Med Trop (Mars), 71, 298‐304.

52.Andriantsoanirina V, Durand R, Pradines B, Baret E, Bouchier C, Ratsimbasoa A and Ménard D. 2011. In vitro susceptibility to pyrimethamine of DHFR I164L single mutant Plasmodium falciparum. Malar J, 10.

53.Andriantsoanirina V, Ménard D, Tuseo L and Durand R. 2010. History and current status of Plasmodium falciparum antimalarial drug resistance in Madagascar. Scand J Infect Dis, 42, 22‐32.

54.Ménard D, Barnadas C, Bouchier C, Henry‐Halldin C, Gray LR, Ratsimbasoa A, Thonier V, Carod J, Domarle O, Colin Y, Bertrand O, Picot J, King CL, Grimberg BT, Mercereau‐Puijalon O and Zimmerman PA. 2010. Plasmodium vivax clinical malaria is commonly observed in Duffy‐negative Malagasy people. Proc Natl Acad Sci USA, 107, 5967‐5971.

55.Kim S, Nguon C, Guillard B, Duong S, Chy S, Sum S, Nhem S, Bouchier C, Tichit M, Christophel E, Taylor WR, Baird JK and Menard D. 2011. Performance of the CareStart™ G6PD deficiency screening test, a point‐of‐care diagnostic for primaquine therapy screening. PLoS o­ne, 6.

56.Manirakiza A, Picard E, Ngbale R, Menard D and Gouandjika‐Vasilache I. 2010. OPV strains circulation in HIV infected infants after National Immunisation Days in Bangui, Central African Republic. BMC Res Notes, 3.

57.Lawaly YR, Sakuntabhai A, Marrama L, Konate L, Phimpraphi W, Sokhna C, Tall A, Sarr FD, Peerapittayamongkol C, Louicharoen C, Schneider BS, Levescot A, Talman A, Casademont I, Menard D, Trape J, Rogier C, Kaewkunwal J, Sura T, Nuchprayoon I, Ariey F, Baril L, Singhasivanon P, Mercereau‐Puijalon O and Paul R. 2010. Heritability of the human infectious reservoir of malaria parasites. PLoS o­ne, 5.

58.Mercereau‐Puijalon O and Ménard D. 2010. Plasmodium vivax and the Duffy antigen: a paradigm revisited. Transfus Clin Biol, 17, 176‐183.

59.Andriantsoanirina V, Ratsimbasoa A, Bouchier C, Tichit M, Jahevitra M, Rabearimanana S, Raherinjafy R, Mercereau‐Puijalon O, Durand R and Ménard D. 2010. Chloroquine clinical failures in P. falciparum malaria are associated with mutant Pfmdr‐1, not Pfcrt in Madagascar. PLoS o­ne, 5.

60.Baker J, Ho M, Pelecanos A, Gatton M, Chen N, Abdullah S, Albertini A, Ariey F, Barnwell J, Bell D, Cunningham J, Djalle D, Echeverry DF, Gamboa D, Hii J, Kyaw MP, Luchavez J, Membi C, Menard D, Murillo C, Nhem S, Ogutu B, o­nyor P, Oyibo W, Wang SQ, McCarthy J and Cheng Q. 2010. Global sequence variation in the histidine‐rich proteins 2 and 3 of Plasmodium falciparum: implications for the performance of malaria rapid diagnostic tests. Malar J, 9.

61.Andriantsoanirina V, Ratsimbasoa A, Bouchier C, Tichit M, Jahevitra M, Rabearimanana S, Raherinjafy R, Mercereau‐Puijalon O, Durand R and Menard D. 2010. Chloroquine Clinical Failures in P. falciparum Malaria Are Associated with Mutant Pfmdr‐1, Not Pfcrt in Madagascar Plos o­ne, 5.

62.Razakandrainibe R, Thonier V, Ratsimbasoa A, Rakotomalala E, Ravaoarisoa E, Raherinjafy R, Andrianantenaina H, Voahanginirina O, Rahasana TE, Carod JF, Domarle O and Menard D. 2009. Epidemiological situation of malaria in Madagascar: baseline data for monitoring the impact of malaria control programmes using serological markers. Acta Trop, 111, 160‐167.

63.Andriantsoanirina V, Lascombes V, Ratsimbasoa A, Bouchier C, Hoffman J, Tichit M, Rabarijaona L, Durand R and Ménard D. 2009. Rapid detection of point mutations in Plasmodium falciparum genes associated with antimalarial drugs resistance by using High‐Resolution Melting analysis. J Microbiol Methods, 78, 165‐170.

64.Barnadas C, Musset L, Legrand E, Tichit M, Briolant S, Fusai T, Rogier C, Bouchier C, Picot S and Ménard D. 2009. High prevalence and fixation of Plasmodium vivax dhfr/dhps mutations related to sulfadoxine/pyrimethamine resistance in French Guiana. Am J Trop Med Hyg, 81, 19‐22.

65.Andriantsoanirina V, Ratsimbasoa A, Bouchier C, Jahevitra M, Rabearimanana S, Radrianjafy R, Andrianaranjaka V, Randriantsoa T, Rason MA, Tichit M, Rabarijaona LP, Mercereau‐Puijalon O, Durand R and Ménard D. 2009. Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr‐1 haplotypes and the decrease of dihydroartemisinin susceptibility. Antimicrob Agents Chemother, 53, 4588‐4597.

66.Baker JT, Gatton M, Ho M, Pelecanos A, Bell D, Barnwell J, Hii J, Ogutu B, Oyibo W, Wang S, Luchavez J, Membi C, Osario L, Kyaw MP, Clowes P, Kroidl I, Gamboa D, Ariey F, Djalle D, Menard D, Povoa MM, Adhin M, Chen N, McCarthy J and Cheng Q. 2009. Global Sequence Variation in the Histidine‐Rich Protein 2 of Plasmodium Falciparum : Implications for Performance of Rapid Diagnostic Tests for Malaria American Journal of Tropical Medicine and Hygiene, 81, 248‐248.

67.Gouandjika‐Vasilache I, Burns CC, Gumede N, Guillot S, Ménard D, Dosseh A, Akoua‐Koffi C, Pallansch MA, Kew OM and Delpeyroux F. 2008. Molecular epidemiology of wild poliovirus type 1 circulation in West and Central Africa, from 1997 to 1999, using genotyping with a restriction fragment length polymorphism assay. Arch Virol, 153, 409‐416.

68.Rakotonirina H, Barnadas C, Raherijafy R, Andrianantenaina H, Ratsimbasoa A, Randrianasolo L, Jahevitra M, Andriantsoanirina V and Ménard D. 2008. Accuracy and reliability of malaria diagnostic techniques for guiding febrile outpatient treatment in malaria‐endemic countries. Am J Trop Med Hyg, 78, 217‐221.

69.Barnadas C, Tichit M, Bouchier C, Ratsimbasoa A, Randrianasolo L, Raherinjafy R, Jahevitra M, Picot S and Ménard D. 2008. Plasmodium vivax dhfr and dhps mutations in isolates from Madagascar and therapeutic response to sulphadoxine‐pyrimethamine. Malar J, 7. Rason MA, Randriantsoa T, Andrianantenaina H, Ratsimbasoa A and Menard D. 2008. Performance and reliability of the SYBR Green I based assay for the routine monitoring of susceptibility of Plasmodium falciparum clinical isolates. Trans R Soc Trop Med Hyg, 102, 346‐351.

70.Ménard D, Ratsimbasoa A, Randrianarivelojosia M, Rabarijaona L, Raharimalala L, Domarle O, Randrianasolo L, Randriamanantena A, Jahevitra M, Andriantsoanirina V, Rason M, Raherinjafy R, Rakotomalala E, Tuseo L and Raveloson A. 2008. Assessment of the efficacy of antimalarial drugs recommended by the National Malaria Control Programme in Madagascar: up‐dated baseline data from randomized and multi‐site clinical trials. Malar J, 7.

71.Dolmazon V, Matsika‐Claquin MD, Manirakiza A, Yapou F, Nambot M and Menard D. 2008. Genetic diversity and genotype multiplicity of Plasmodium falciparum infections in symptomatic individuals living in Bangui (CAR). Acta Trop, 107, 37‐42.

72.Ménard D, Andriantsoanirina V, Jahevitra M, Barnadas C, Tichit M, Bouchier C and Sibley CH. 2008. Dihydrofolate reductase I164L mutation in Plasmodium falciparum, Madagascar. Emerg Infect Dis, 14, 1166‐1167.

73.Durand R, Ariey F, Cojean S, Fontanet A, Ranaivo L, Ranarivelo L, Vonimpaisomihanta JA, Menard D, Pietra V, Le Bras J, Modiano D and Randrianarivelojosia M. 2008. Analysis of circulating populations of Plasmodium falciparum in mild and severe malaria in two different epidemiological patterns in Madagascar. Trop Med Int Health, 13, 1392‐1399.

74.Barnadas C, Ratsimbasoa A, Tichit M, Bouchier C, Jahevitra M, Picot S and Ménard D. 2008. Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt‐o genes. Antimicrob Agents Chemother, 52, 4233‐4240.

75.Mariette N, Barnadas C, Bouchier C, Tichit M and Ménard D. 2008. Country‐wide assessment of the genetic polymorphism in Plasmodium falciparum and Plasmodium vivax antigens detected with rapid diagnostic tests for malaria. Malar J, 7.

76.Ratsimbasoa A, Fanazava L, Radrianjafy R, Ramilijaona J, Rafanomezantsoa H and Ménard D. 2008. Evaluation of two new immunochromatographic assays for diagnosis of malaria. Am J Trop Med Hyg, 79, 670‐672.

77.Ratsimbasoa A, Randriamanantena A, Raherinjafy R, Rasoarilalao N and Ménard D. 2007. Which malaria rapid test for Madagascar? Field and laboratory evaluation of three tests and expert microscopy of samples from suspected malaria patients in Madagascar. Am J Trop Med Hyg, 76, 481‐485.

78.Ménard D, Andrianina NN, Ramiandrasoa Z, Randriamanantena A, Rasoarilalao N, Jahevitra M, Ratsimbasoa A, Tuseo L and Raveloson A. 2007. Randomized clinical trial of artemisinin versus non‐artemisinin combination therapy for uncomplicated falciparum malaria in Madagascar. Malar J, 6.

79.Ekala M, Khim N, Legrand E, Randrianarivelojosia M, Jambou R, Fandeur T, Menard D, Assi S, Henry M, Rogier C, Bouchier C and Mercereau‐Puijalon O. 2007. Sequence analysis of Plasmodium falciparum cytochrome b in multiple geographic sites. Malar J, 6.

80.Barnadas C, Ratsimbasoa A, Ranaivosoa H, Ralaizandry D, Raveloariseheno D, Rabekotonorina V, Picot S and Ménard D. 2007. Short report: prevalence and chloroquine sensitivity of Plasmodium malariae in Madagascar. Am J Trop Med Hyg, 77, 1039‐1042.

81.Ménard D, Randrianarivo‐Solofoniaina AE, Ahmed BS, Jahevitra M, Andriantsoanirina V, Rasolofomanana JR and Rabarijaona LP. 2007. Drug‐resistant malaria parasites introduced into Madagascar from Comoros Islands. Emerg Infect Dis, 13, 1759‐1762.

82.Matsika‐Claquin MD, Ménard D, Fontanet AL, Ngwhotue A, Sarda J and Talarmin A. 2006. Efficacy of chloroquine‐proguanil malaria prophylaxis in a non‐immune population in Bangui, Central African Republic: a case‐control study. Trans R Soc Trop Med Hyg, 100, 381‐386

83.Menard D, Djalle D, Yapou F, Manirakiza A and Talarmin A. 2006. Frequency distribution of antimalarial drug‐resistant alleles among isolates of Plasmodium falciparum in Bangui, Central African Republic. Am J Trop Med Hyg, 74, 205‐210.

84.Gouandjika‐Vasilache I, Waku‐Kouomou D, Ménard D, Beyrand C, Guye F, Ngoay‐Kossy JC, Sélekon B and Wild TF. 2006. Cocirculation of measles virus genotype B2 and B3.1 in Central African Republic during the 2000 measles epidemic. J Med Virol, 78, 964‐970.

85.Ratsimbasoa A, Randrianarivelojosia M, Millet P, Soarès JL, Rabarijaona L, Rakotoson B, Malvy D and Ménard D. 2006. Use of pre‐packaged chloroquine for the home management of presumed malaria in Malagasy children. Malar J, 5.

86.Ménard D, Maïro A, Mandeng M, Doyemet P, Koyazegbe Td, Rochigneux C and Talarmin A. 2005. Evaluation of rapid HIV testing strategies in under equipped laboratories in the Central African Republic. J Virol Methods, 126, 75‐80.

87.Menard D, Madji N, Manirakiza A, Djalle D, Koula MR and Talarmin A. 2005. Efficacy of chloroquine, amodiaquine, sulfadoxine‐pyrimethamine, chloroquine‐sulfadoxine‐pyrimethamine combination, and amodiaquine‐sulfadoxine‐pyrimethamine combination in Central African children with noncomplicated malaria. Am J Trop Med Hyg, 72, 581‐585.

88.Menard D, Djalle D, Manirakiza A, Yapou F, Siadoua V, Sana S, Matsika‐Claquin MD, Nestor M and Talarmin A. 2005. Drug‐resistant malaria in Bangui, Central African Republic: an in vitro assessment. Am J Trop Med Hyg, 73, 239‐243.

89.Menard D, Matsika‐Claquin MD, Djalle D, Yapou F, Manirakiza A, Dolmazon V, Sarda J and Talarmin A. 2005. Association of failures of seven‐day courses of artesunate in a non‐immune population in Bangui, Central African Republic with decreased sensitivity of Plasmodium falciparum. Am J Trop Med Hyg, 73, 616‐621.

90.Gouandjika‐Vasilache I, Kipela J, Daba RM, Mokwapi V, Nambozuina E, Cabore J, Pasi O and Menard D. 2005. Wild poliovirus type 1, Central African Republic. Emerg Infect Dis, 11, 1498‐1499.

91.Matsika‐Claquin MD, Massanga M, Ménard D, Mazi‐Nzapako J, Ténegbia J, Mandeng M, Willybiro‐Sacko J, Fontanet A and Talarmin A. 2004. HIV epidemic in Central African Republic: high prevalence rates in both rural and urban areas. J Med Virol, 72, 358‐362.

92.Menard D, Mandeng MJ, Tothy MB, Kelembho EK, Gresenguet G and Talarmin A. 2003. Immunohematological reference ranges for adults from the Central African Republic. Clin Diagn Lab Immunol, 10, 443‐445.

93.Ménard D, Mavolomadé EE, Mandeng M and Talarmin A. 2003. Advantages of an alternative strategy based o­n consecutive HIV serological tests for detection of HIV antibodies in Central African Republic. J Virol Methods, 111, 129‐134.

94.Hima‐Lerible H, Menard D and Talarmin A. 2003. Antimicrobial resistance among uropathogens that cause community‐acquired urinary tract infections in Bangui, Central African Republic Journal of Antimicrobial Chemotherapy, 51, 192‐194.

95.Razanamparany VR, Ménard D, Aurégan G, Gicquel B and Chanteau S. 2002. Extrapulmonary and pulmonary tuberculosis in antananarivo (madagascar): high clustering rate in female patients. J Clin Microbiol, 40, 3964‐3969.

96.Menard D, Gouandjika I, Mberio‐Yaah F, Mokwapi F, Soro B, Djalai MI, Yam A, Maiga Z and Morvan JM. 2002. Results of active surveillance of acute flaccid paralysis in the Central African Republic and Chad from 1995 to 2000 Medecine tropicale : revue du Corps de sante colonial, 62, 63‐9.

97.Ménard D. 2001. [Toxoplasmosis, rubella, syphilis, hepatitis B and HIV infection in women being followed for pregnancy in a population o­n the east coast of New Caledonia ]. Bull Soc Pathol Exot, 94, 403‐405.

98.Rasolofo‐Razanamparany V, Ménard D, Ratsitorahina M, Aurégan G, Gicquel B and Chanteau S. 2000. Transmission of tuberculosis in the prison of Antananarivo (Madagascar). Res Microbiol, 151, 785‐795.

99.Rasolofo‐Razanamparany V, Ménard D, Rasolonavalona T, Ramarokoto H, Rakotomanana F, Aurégan G, Vincent V and Chanteau S. 1999. Prevalence of Mycobacterium bovis in human pulmonary and extra‐pulmonary tuberculosis in Madagascar. Int J Tuberc Lung Dis, 3, 632‐634.

100.Menard D, Paris L and Danis M. 1999. [Immunoblot applied to the diagnosis of congenital toxoplasmosis]. Pathol Biol (Paris), 47, 797‐804.

101.Gautret P,

Pape PL

, Biard JF, Menard D, Verbist JF and Marjolet M. 1998. The effects of bistramides o­n rodent malaria Acta Parasitologica, 43, 50‐53.